| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 12/11/2013 | CN102614121B Silibinin injection composition and preparation process |
| 12/11/2013 | CN102604082B Cis-platinum coordination compound and preparation method thereof |
| 12/11/2013 | CN102599512B Sea buckthorn nutrition powder and preparation method thereof |
| 12/11/2013 | CN102579411B Miao national herb neck and waist health care paste and technology for producing same |
| 12/11/2013 | CN102552210B Entecavir capsule and preparation method thereof |
| 12/11/2013 | CN102552127B Ornidazole injection |
| 12/11/2013 | CN102526479B Health-care medicine formula with functions of enhancing immunity and lowering blood sugar |
| 12/11/2013 | CN102526042B Stable liquid medicinal composition |
| 12/11/2013 | CN102504214B Process method for catalytic synthesis of poly lactic acid-glycolic acid by using bionic organic guanidinium |
| 12/11/2013 | CN102470183B Pharmaceutical composition containing dimethicone/ simethicone |
| 12/11/2013 | CN102408445B Hexaminoacid ester phenoxyl cyclotriphosphazene fluorescent nano-microsphere and preparation method thereof |
| 12/11/2013 | CN102321239B Preparation method of water-soluble toluylene compound prodrugs |
| 12/11/2013 | CN102166376B Ophthalmic medicine-carried amnion and preparation method thereof |
| 12/11/2013 | CN102133205B Preparation method of glipizide osmotic pump controlled release tablet |
| 12/11/2013 | CN102125517B Application of low-concentration vesicular phospholipid gel as slow release carrier for small-molecule peptide drug |
| 12/11/2013 | CN102008728B Liquid depot formulations |
| 12/11/2013 | CN101914161B Fusion protein HGF alpha-Fc for restraining tumor growth and application thereof |
| 12/11/2013 | CN101744788B Omeprazole enteric coated tablet and preparation method thereof |
| 12/10/2013 | US8604169 Nucleic acids and corresponding proteins entitled 251P5G2 useful in treatment and detection of cancer |
| 12/10/2013 | US8604159 Method for preparing functionalized polymers from polymer alcohols |
| 12/10/2013 | US8604127 Conjugate of catechol-modified polyethylene glycol with protein or peptide and preparation method thereof |
| 12/10/2013 | US8604079 Solid cosmetic composition |
| 12/10/2013 | US8604076 Method for producing a pharmaceutical composition comprising rotigotine |
| 12/10/2013 | US8604072 Treatment using dantrolene |
| 12/10/2013 | US8603566 Cross-linked biopolymers, related compounds and methods of use |
| 12/10/2013 | US8603539 Compositions for drug delivery |
| 12/10/2013 | US8603535 Stable formulations for lyophilizing therapeutic particles |
| 12/10/2013 | US8603515 Pharmaceutical formulation |
| 12/10/2013 | US8603488 Photoautotrophic growth of microalgae for omega-3 fatty acid production |
| 12/10/2013 | US8603471 Methods and compositions for preventing the onset of type 1 diabetes |
| 12/10/2013 | US8603454 Cyclodextrin-based polymers for therapeutics delivery |
| 12/10/2013 | US8603437 Methods for tumor diagnosis and therapy |
| 12/10/2013 | US8603076 Microfabricated nanopore device for sustained release of therapeutic agent |
| 12/10/2013 | CA2623749C Reduction of saltiness with sweeteners |
| 12/10/2013 | CA2612762C Psma antibody-drug conjugates |
| 12/10/2013 | CA2589975C Releasable polymeric conjugates based on aliphatic biodegradable linkers |
| 12/10/2013 | CA2580141C Cysteine engineered antibodies and conjugates |
| 12/10/2013 | CA2557848C Ion binding compositions |
| 12/10/2013 | CA2541243C Pressure-sensitive adhesive sheet for application to skin |
| 12/10/2013 | CA2502367C Antibodies that bind cell-associated ca 125/o772p and methods of use thereof |
| 12/10/2013 | CA2499220C Local vascular delivery of etoposide in combination with rapamycin to prevent restenosis following vascular injury |
| 12/10/2013 | CA2495442C Backbone-substituted bifunctional dota ligands, complexes and compositions thereof, and methods of using same |
| 12/10/2013 | CA2489250C Composition comprising viscous fibers and viscosity-lowering proteins |
| 12/10/2013 | CA2385528C Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
| 12/05/2013 | WO2013181597A2 Thiol-ene click chemistry for drug conjugates |
| 12/05/2013 | WO2013181471A2 Matrix metalloproteinase cleavable protein polymers for cancer gene therapy |
| 12/05/2013 | WO2013181174A2 Solid dosage formulations of an orexin receptor antagonist |
| 12/05/2013 | WO2013180458A1 Crosslinked hydrogel for drug delivery, and method for preparing the hydrogel |
| 12/05/2013 | WO2013180253A1 pH-SENSITIVE CARRIER AND METHOD FOR PRODUCTION THEREOF, pH-SENSITIVE MEDICINE AND pH-SENSITIVE PHARMACEUTICAL COMPOSITION EACH CONTAINING SAID CARRIER, AND CULTURE METHOD USING SAID pH-SENSITIVE MEDICINE OR SAID pH-SENSITIVE PHARMACEUTICAL COMPOSITION |
| 12/05/2013 | WO2013180249A1 Cellulose powder |
| 12/05/2013 | WO2013180248A1 Cellulose powder |
| 12/05/2013 | WO2013180246A1 Cellulose powder |
| 12/05/2013 | WO2013180229A1 Composition for hair growth |
| 12/05/2013 | WO2013180140A1 Dihydroorotic acid dehydrogenase inhibitor |
| 12/05/2013 | WO2013180038A1 Single-stranded nucleic acid molecule for regulating expression of gene having delivering function |
| 12/05/2013 | WO2013180008A1 Sebum-absorbent pasting material, and method for manufacturing same |
| 12/05/2013 | WO2013179669A1 Carrier for gene introduction use, gene introduction agent, methods for producing said carrier and said gene introduction agent, and method for introducing gene into cell |
| 12/05/2013 | WO2013179302A1 Oral anti-inflammatory formulation comprising potentised cytokine |
| 12/05/2013 | WO2013179258A1 New release system of hydrophobic proteins |
| 12/05/2013 | WO2013179248A1 Pharmaceutical compositions of pemetrexed |
| 12/05/2013 | WO2013179057A1 Method of synthesising sulforaphane |
| 12/05/2013 | WO2013179056A1 Sulforaphane isolation and purification |
| 12/05/2013 | WO2013179014A1 Nanoparticles with attached dna repair inhibitors and nuclear localisation signal elements |
| 12/05/2013 | WO2013178974A1 Process for expression of crm197 |
| 12/05/2013 | WO2013178954A1 Improved organic-inorganic hybrid solid having a modified outer surface |
| 12/05/2013 | WO2013178812A1 Risperidone or paliperidone implant formulation |
| 12/05/2013 | WO2013178811A1 Paliperidone implant formulation |
| 12/05/2013 | WO2013178788A2 Manufacture of degarelix |
| 12/05/2013 | WO2013178758A1 O/w-emulsion-type topical pharmaceutical compositions containing a retinoid |
| 12/05/2013 | WO2013178749A1 Lipid nanocapsules comprising a retinoid, nanodispersion and composition containing same, method of producing same and use thereof in dermatology |
| 12/05/2013 | WO2013178744A1 Emulsion-type, emulsifier-free topical compositions containing stabilising particles |
| 12/05/2013 | WO2013178743A1 Microcapsules containing retinoids, method for preparing same, and pharmaceutical compositions containing same |
| 12/05/2013 | WO2013178627A2 Protein assembler |
| 12/05/2013 | WO2013178214A1 Pharmaceutical pemetrexed solution |
| 12/05/2013 | WO2013177922A1 Polypeptide for treating alzheimer's disease and genetic vaccine |
| 12/05/2013 | WO2013177833A1 Dysmenorrhea-treating medicament and preparation method therefor |
| 12/05/2013 | WO2013109354A3 Etravirine formulations and uses thereof |
| 12/05/2013 | WO2013100882A3 Combinations of diacerein and non-steroidal inflammation drugs |
| 12/05/2013 | WO2013095318A3 Orally-disintegrating formulations of flurbiprofen |
| 12/05/2013 | US20130324950 Transdermal delivery system containing galantamine or salts thereof |
| 12/05/2013 | US20130324759 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers |
| 12/05/2013 | US20130324706 Branched Linker for Protein Drug Conjugates |
| 12/05/2013 | US20130324569 Pegylated cyclopamine analogue, preparation method and uses thereof |
| 12/05/2013 | US20130324548 Chemoembolization composition comprising anti-angiogenic agents |
| 12/05/2013 | US20130324534 Combination of brimonidine and timolol for topical ophthalmic use |
| 12/05/2013 | US20130324510 Delivery of hydrophobic bioactive agents |
| 12/05/2013 | US20130324509 Spinal cord injury, inflammation, and immune-disease: local controlled release of therapeutic agents |
| 12/05/2013 | US20130324502 Novel formulations for dermal, transdermal and mucosal use 1 |
| 12/05/2013 | US20130324490 Biodegradable, water soluble and ph responsive poly(organo)phosphazenes |
| 12/05/2013 | US20130324481 Sustained release eye drop formulations |
| 12/05/2013 | US20130324470 Cross-linked gelatin composition comprising a wetting agent |
| 12/05/2013 | US20130323324 Vanadium and vanadyl amino acid complexes |
| 12/05/2013 | US20130323320 pH SENSITIVE CARRIER AND PREPARATION METHOD THEREOF, AND pH SENSITIVE DRUG AND pH SENSITIVE DRUG COMPOSITION EACH CONTAINING THE CARRIER, AND METHOD FOR TREATING OR PREVENTING DISEASES USING THE SAME |
| 12/05/2013 | US20130323316 Injectable microspheres for dermal augmentation and tissue bulking |
| 12/05/2013 | US20130323304 Methods For Enhancing The Release And Absorption of Water Insoluble Active Agents |
| 12/05/2013 | US20130323293 Glp-1 analogue composition for microneedle devices |
| 12/05/2013 | US20130323270 Cyclosporine emulsion |
| 12/05/2013 | US20130323269 Methods and compositions for delivery of active agents |
| 12/05/2013 | US20130323268 Cytotoxic agents comprising new ansamitocin derivatives |
| 12/05/2013 | US20130323246 Use of mdl-1 antagonists to treat spondylarthropathy |